Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
BIO-RAD LABORATORIES

HUMAN GMBH

HUMAN offers a broad portfolio of in vitro diagnostic products with more than 400 products in 12 areas covering the w... read more Featured Products: More products

Download Mobile App





HUMAN Diagnostics Showcases Innovative FIA and Hematology Solutions

By LabMedica International staff writers
Posted on 24 Jul 2023

HUMAN Diagnostics (Wiesbaden, Germany), a leading global provider of in-vitro diagnostic solutions, is participating in the 2023 AACC Clinical Lab Expo taking place from July 25th to 27th in Anaheim, CA, USA. As a prominent exhibitor, HUMAN is located at Booth #921, where the company is showcasing its cutting-edge products and engaging with industry professionals, researchers, and healthcare experts. The company's presence at the expo reaffirms its commitment to delivering high-quality diagnostic solutions that contribute to advancing patient care and laboratory excellence.

Among the products being featured at the exhibition is the HumaCount 5D CRP, an innovative hematology analyzer that provides rapid and precise measurement of C-reactive protein (CRP), a crucial biomarker for inflammation assessment. With its advanced technology and user-friendly interface, HumaCount 5D CRP delivers reliable results and enhances laboratory efficiency. Also being highlighted at the show is the HumaNex A1c Variant which offers a breakthrough in glycated hemoglobin (A1c) testing. This fully automated assay delivers accurate results for A1c testing, even in the presence of hemoglobin variants, ensuring reliable diabetes management and monitoring.

The company is also highlighting the HumaFIA system, a high-performance fluorescence immunoassay analyzer designed for rapid and sensitive measurement of various analytes. With its versatility and efficiency, HumaFIA facilitates precise diagnostics across a wide range of applications. At the event, HUMAN's team of experts is available to discuss the company's comprehensive product portfolio, provide demonstrations, and answer any questions from attendees.

"We are excited to participate in the prestigious AACC Clinical Lab Expo and present our latest advancements in diagnostic solutions," said Thomas Roesser, Vice President International Sales. "At HUMAN, we are dedicated to developing innovative products that empower healthcare professionals to make informed decisions and improve patient outcomes."

Related Links:
HUMAN Diagnostics 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.